Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD7+ Lymphoma”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Early research (Phase 1)Looking for participantsNCT06934382
What this trial is testing

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Stephan Grupp MD PhD 33
Early research (Phase 1)WithdrawnNCT05513612
What this trial is testing

Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)B-cell Non-Hodgkin's Lymphoma (B-NHL)Multiple Myeloma (MM)+2 more
Shanghai Pudong Hospital
Early research (Phase 1)Study completedNCT04840875
What this trial is testing

Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma

Who this might be right for
T Cell LymphomaT-cell Leukemia
Beijing Boren Hospital 16
Early research (Phase 1)Looking for participantsNCT05995028
What this trial is testing

Universal 4SCAR7U Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Very early researchUnknownNCT05979792
What this trial is testing

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Zhao Weili 35
Early research (Phase 1)UnknownNCT04599556
What this trial is testing

Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy

Who this might be right for
CD7+ Acute LeukemiaCD7+ Lymphoma
Zhejiang University 81
Early research (Phase 1)Not Yet RecruitingNCT07623681
What this trial is testing

Single-arm, Open-label, Dose-escalating Phase I Clinical Study of PA3-17 Injection in Children and Adolescents With Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

Who this might be right for
CD7+ T-ALL/LBL
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 12
Early research (Phase 1)UnknownNCT04934774
What this trial is testing

Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-cell Non-Hodgkin Lymphoma
iCell Gene Therapeutics 20
Early research (Phase 1)Study completedNCT04572308
What this trial is testing

Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells

Who this might be right for
T-cell Acute Lymphoblastic Leukemia/Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 20
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Testing effectiveness (Phase 2)UnknownNCT04033302
What this trial is testing

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07117305
What this trial is testing

CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
CD7+ LymphomaT Cell Lymphoma
Zhengzhou University 38
Not applicableUnknownNCT04620655
What this trial is testing

RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
T Acute Lymphoblastic LeukemiaT-lymphoblastic Lymphoma
Min Xiang 24
Not applicableUnknownNCT04916860
What this trial is testing

Clinical Study of SenL-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Who this might be right for
SenL-T7 CAR T Cells for CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 100
Very early researchWithdrawnNCT04860817
What this trial is testing

Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBL

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-lymphoblastic Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Early research (Phase 1)Looking for participantsNCT05528887
What this trial is testing

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Who this might be right for
Relapsed/Refractory Hematological MalignanciesLymphomaMyeloma+1 more
The Affiliated People's Hospital of Ningbo University 10
Early research (Phase 1)UnknownNCT05127135
What this trial is testing

Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies

Who this might be right for
T-Acute Lymphoblastic LeukemiaT-cell Non-Hodgkin LymphomaT-cell Acute Lymphoblastic Lymphoma
Fundamenta Therapeutics, Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT02742727
What this trial is testing

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Who this might be right for
Acute Myeloid LeukemiaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaT-cell Prolymphocytic Leukemia+6 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05885464
What this trial is testing

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

Who this might be right for
Lymphoblastic LymphomaT-Cell Lymphoblastic Leukemia/LymphomaLymphoblastic Leukemia
Beam Therapeutics Inc. 5
Early research (Phase 1)Active Not RecruitingNCT05377827
What this trial is testing

Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies

Who this might be right for
T-Cell Non-Hodgkin LymphomaAcute Myeloid LeukemiaAngioimmunoblastic T-cell Lymphoma+12 more
Washington University School of Medicine 6
Load More Results